Search Results

There are 17887 results for: content related to: Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Pages: 765–769, D Goldberg, JD Lewis, SD Halpern, Mark Weiner and Vincent Lo Re III

    Version of Record online : 3 JUN 2012, DOI: 10.1002/pds.3290

  3. You have free access to this content
    Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C–Infected Patients With Compensated and Decompensated Cirrhosis

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 715–725, Varun Saxena, Lisa Nyberg, Marypat Pauly, Aditi Dasgupta, Anders Nyberg, Barbara Piasecki, Bradley Winston, Jacquelyn Redd, Joanna Ready and Norah A. Terrault

    Version of Record online : 30 JUL 2015, DOI: 10.1002/hep.27922

  4. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  5. You have free access to this content
    Hepatology Clinical

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue S2, October 2014, Pages: 68–101,

    Version of Record online : 13 OCT 2014, DOI: 10.1111/jgh.12736_5

  6. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 598–607, Man Young Park, Dukyong Yoon, KiYoung Lee, Seok Yun Kang, Inwhee Park, Suk-Hyang Lee, Woojae Kim, Hye Jin Kam, Young-Ho Lee, Ju Han Kim and Rae Woong Park

    Version of Record online : 6 APR 2011, DOI: 10.1002/pds.2139

  7. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  8. You have free access to this content
    Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 1, January 2017, Pages: 150–159, A. A. Butt, Y. Ren, K. Marks, O. S. Shaikh, K. E. Sherman and For the ERCHIVES study

    Version of Record online : 4 NOV 2016, DOI: 10.1111/apt.13837

  9. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  10. You have free access to this content
    Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfection

    Hepatology

    Volume 56, Issue 5, November 2012, Pages: 1688–1698, Vincent Lo Re III, Jessica Volk, Craig W. Newcomb, Yu-Xiao Yang, Cristin P. Freeman, Sean Hennessy, Jay R. Kostman, Pablo Tebas, Mary B. Leonard and A. Russell Localio

    Version of Record online : 14 OCT 2012, DOI: 10.1002/hep.25866

  11. You have free access to this content
    Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER–Medicare database

    Hepatology

    Volume 65, Issue 1, January 2017, Pages: 122–133, Neehar D. Parikh, Vincent D. Marshall, Amit G. Singal, Hari Nathan, Anna S. Lok, Rajesh Balkrishnan and Vahakn Shahinian

    Version of Record online : 25 NOV 2016, DOI: 10.1002/hep.28881

  12. Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients

    Journal of Medical Virology

    Volume 77, Issue 3, November 2005, Pages: 367–373, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chang Wook Kim, Soon Woo Nam, Chang Don Lee, Young Sok Lee, Sang Bok Cha and Kyu Won Chung

    Version of Record online : 19 SEP 2005, DOI: 10.1002/jmv.20465

  13. Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis

    Liver International

    Volume 36, Issue 7, July 2016, Pages: 954–962, Jia-Horng Kao, Donald M. Jensen, Michael P. Manns, Ira Jacobson, Hiromitsu Kumada, Joji Toyota, Jeong Heo, Boris Yoffe, William Sievert, Fernando Bessone, Cheng-Yuan Peng, Stuart K. Roberts, Youn-Jae Lee, Rafia Bhore, Patricia Mendez, Eric Hughes and Stephanie Noviello

    Version of Record online : 24 JAN 2016, DOI: 10.1111/liv.13049

  14. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  15. You have free access to this content
    Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control study

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2221–2230, Srinevas K. Reddy, J. Wallis Marsh, Patrick R. Varley, Brady K. Mock, Kapil B. Chopra, David A. Geller and Allan Tsung

    Version of Record online : 14 OCT 2012, DOI: 10.1002/hep.25935

  16. You have free access to this content
    Clinical outcome of hepatitis C as a function of mode of transmission

    Hepatology

    Volume 28, Issue 2, August 1998, Pages: 562–567, Stuart C. Gordon, Nasser Bayati and Ann L. Silverman

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510280238

  17. You have free access to this content
    Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1004–1012, Bashar A. Aqel, Surakit Pungpapong, Michael Leise, K. Tuesday Werner, Amy E. Chervenak, Kymberly D. Watt, Jennifer L. Murphy, Kristen Ryland, Andrew P. Keaveny, Ryan McLemore and Hugo E. Vargas

    Version of Record online : 7 AUG 2015, DOI: 10.1002/hep.27937

  18. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 10, November 2016, Pages: 1051–1061, D. Bettinger, M. Schultheiss, T. Boettler, M. Muljono, R. Thimme and M. Rössle

    Version of Record online : 27 SEP 2016, DOI: 10.1111/apt.13809

  19. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue 7, July 2009, Pages: 1276–1283, Nobuyuki Toshikuni, Akiyoshi Izumi, Ken Nishino, Nobu Inada, Ritsuko Sakanoue, Ryumei Yamato, Mitsuhiko Suehiro, Miwa Kawanaka and Gotaro Yamada

    Version of Record online : 6 APR 2009, DOI: 10.1111/j.1440-1746.2009.05851.x

  20. Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: Incidence and risk factors

    Journal of Gastroenterology and Hepatology

    Volume 11, Issue 2, February 1996, Pages: 143–147, I-SHYAN SHEEN, YUN-FAN LIAW, SHI-MING LIN and CHIA-MING CHU

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1996.tb00051.x